EUA
Access SARS-CoV-2 IgM
FDA Emergency Use Authorization · Beckman Coulter, Inc. · Dec 13, 2021
Key facts
| Product | Access SARS-CoV-2 IgM |
|---|---|
| Company | Beckman Coulter, Inc. |
| Product type | IgM, CLIA |
| Date | Dec 13, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: